Tying claim against CVS could affect Aetna deal, observers say
As the Department of Justice reviews CVS Health’s $69 billion purchase of Aetna, a healthcare information technology company has sued the pharmacy chain and benefit manager for allegedly forcing the plaintiff’s customers to use its subsidiary Wellpartner’s services in violation of federal antitrust laws.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10